Genovn Therapeutics (Suzhou) Co., Ltd.
Genovn Therapeutics (Suzhou) Co., Ltd.
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| IL-15 Enhanced NK Cell Therapy for Solid Tumors | Neoplasm Metastasis, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, metastatic malignant neoplasm, neoplasm | Recruiting | Early phase 1 | 2026-09-30 | NCT07621471 |